NDC Package 43066-090-25 Prochlorperazine Edisylate

Injection Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
43066-090-25
Package Description:
25 VIAL in 1 CARTON / 2 mL in 1 VIAL (43066-090-01)
Product Code:
Proprietary Name:
Prochlorperazine Edisylate
Non-Proprietary Name:
Prochlorperazine Edisylate
Substance Name:
Prochlorperazine Edisylate
Usage Information:
To control severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.
11-Digit NDC Billing Format:
43066009025
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2102949 - prochlorperazine 5 MG/ML Injectable Solution
  • RxCUI: 2102949 - prochlorperazine (as edisylate) 5 MG/ML Injectable Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Baxter Healthcare Corporation
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    ANDA214379
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-03-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 43066-090-25?

    The NDC Packaged Code 43066-090-25 is assigned to a package of 25 vial in 1 carton / 2 ml in 1 vial (43066-090-01) of Prochlorperazine Edisylate, a human prescription drug labeled by Baxter Healthcare Corporation. The product's dosage form is injection and is administered via intramuscular; intravenous form.

    Is NDC 43066-090 included in the NDC Directory?

    Yes, Prochlorperazine Edisylate with product code 43066-090 is active and included in the NDC Directory. The product was first marketed by Baxter Healthcare Corporation on May 03, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 43066-090-25?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 43066-090-25?

    The 11-digit format is 43066009025. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-243066-090-255-4-243066-0090-25